Lonza Signs Deal with Scarab Genomics

Lonza says it has entered into a preferred marketing and sales agreement with biotechnology company Scarab Genomics (Madison, WI) for Scarab Genomics’ Clean Genome E. coli. Financial details were not disclosed. Lonza will support Scarab Genomics’ business development activities and becomes the preferred marketing provider for the Clean Genome technology, giving Lonza customers access to the platform for protein and plasmid DNA production. Lonza and Scarab Genomics will also work together to develop new microbial expression technologies, under the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers